Page last updated: 2024-12-05
n,n-diethylacetamide
Cross-References
ID Source | ID |
PubMed CID | 12703 |
CHEMBL ID | 3184758 |
SCHEMBL ID | 18738 |
MeSH ID | M0101893 |
Synonyms (48)
Synonym |
6yo81d7st6 , |
n,n-diaethylacetamid |
4-04-00-00349 (beilstein handbook reference) |
unii-6yo81d7st6 |
diethylacetamide |
acetic acid, amide, n,n-diethyl |
ai3-02182 |
nsc 101 |
einecs 211-685-2 |
brn 1209428 |
n,n-diaethylacetamid [german] |
hsdb 5513 |
inchi=1/c6h13no/c1-4-7(5-2)6(3)8/h4-5h2,1-3h |
acetamide, n,n-diethyl- |
nsc-101 |
685-91-6 |
n,n-diethylacetamide |
nsc101 |
wln: 2n2&v1 |
n,n-diethylacetamide, 97% |
n-acetyldiethylamine , |
D0461 |
AKOS003862095 |
NCGC00248816-01 |
cas-685-91-6 |
dtxsid9020459 , |
dtxcid10459 |
tox21_200733 |
NCGC00258287-01 |
n,n-diethyl-acetamide |
FT-0629458 |
n,n-diethylacetamide [hsdb] |
SCHEMBL18738 |
n,n-di ethylacetamide |
n,n-diethylethanamide |
ch3con(c2h5)2 |
acetic acid diethylamide |
CHEMBL3184758 |
mfcd00009047 |
H11276 |
DS-3397 |
n,n-diethyl acetamide |
EN300-107551 |
SY037752 |
n-diethylacetamide |
Q27265731 |
n.n-diethyl acetamide |
CS-W009545 |
Protein Targets (3)
Potency Measurements
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 31.62
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 31.62 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.14 (4.65) | Search Engine Demand Index | 39.34 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |